XML 28 R17.htm IDEA: XBRL DOCUMENT v3.25.3
Incentive Stock Programs
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Incentive Stock Programs
Note 8 — Incentive Stock Programs

In the first nine months of 2025, Abbott granted 1,482,667 stock options, 364,498 restricted stock awards, and 4,397,394 restricted stock units under its incentive stock program. At September 30, 2025, 51 million shares were reserved for future grants. Information regarding the number of options outstanding and exercisable at September 30, 2025, is as follows:

OutstandingExercisable
Number of shares 22,690,333 19,485,032 
Weighted average remaining life (years)
4.74.1
Weighted average exercise price $90.17 $84.79 
Aggregate intrinsic value (in millions)
$995 $958 

The total unrecognized share-based compensation cost at September 30, 2025, amounted to $577 million, which is expected to be recognized over the next three years.